Communication Tag for a Drug Product A Smart Label That Lets a Phone Verify Your Medication

This patent describes a medication delivery device, such as an injector, fitted with a label that carries a communication tag a phone can read to check that the device is genuine and to track it. It comes from Eli Lilly and Company, the American pharmaceutical maker.

The Problem

Counterfeit medicines are a serious and global problem. Counterfeiters package fake products to look as though a trusted manufacturer made them, when they did not. A patient who takes a counterfeit medication may be harmed by what is actually in it, and may also go untreated for the condition the real medicine was meant to address. That puts both patients and manufacturers at risk. There is a clear need for a simple way for an ordinary person to confirm, at the point of use, that a medication delivery device is authentic and has not been tampered with or diverted.

What This Invention Does

The invention is a medication delivery device with a housing, a reservoir sized to hold the medication, an actuating button to start an injection, and a label affixed to the housing. The label includes a communication tag. When a mobile device, typically a smartphone, is brought near the tag and reads it, the tag causes the phone to launch a web browser and open a specific web address. Through that link, the phone receives data from the tag and uses it to verify or authenticate an aspect of the device, or to track who has possession of it. In everyday terms, a patient or pharmacist could tap their phone to the injector and be taken to a page that confirms the product is genuine, while the manufacturer gains a way to follow the device through the supply chain.

Key Features

• Integrated communication tag. A readable tag is built into the device label.
• Phone-triggered link. Reading the tag launches a browser and opens a specific web address.
• Authentication. The received data lets the phone verify that the device is genuine.
• Possession tracking. The system can track who holds the device through the supply chain.
• Familiar form factor. The tag sits on a standard injector with reservoir and actuating button.

Who Is Behind It

The applicant is Eli Lilly and Company, a major pharmaceutical company headquartered in Indianapolis, known for diabetes, obesity, and other treatments often delivered by injection devices. The named inventors are Douglas James Gorr, Senthil Subramanian Rajaratnam, and Louis Stevens Somlai. This filing is a divisional application from an earlier related application.

Why It Matters

As more medicines are delivered through self-injection devices used at home, the ability to confirm authenticity without special equipment becomes valuable for safety. Linking a tap of a phone to verification and tracking helps protect patients from counterfeits and gives manufacturers better visibility of their products. Securing the technology in Australia supports the company’s interests as connected drug-delivery devices become more common in the local market.

Related Concepts

• Near-field communication – a common tag technology a phone can read by tapping.
• Counterfeit medications – the safety problem this invention addresses.
• Autoinjector – the kind of delivery device the tag is attached to.
• Track and trace – the supply-chain visibility the system supports.
• Eli Lilly and Company – the company behind the application.

---

AU 2026201941 was published in the Australian Official Journal of Patents on 2 April 2026 and is open for public inspection. Patent applications represent inventions that are sought to be protected and do not necessarily reflect commercially available products.